Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas A Fitzgerald Insider Profile
4 Followers
Thomas A Fitzgerald, Interim CEO, CFO, Director at TransCode Therapeutics, holds 56.32K shares in TransCode Therapeutics (Ticker: RNAZ). Most recently, Thomas A Fitzgerald Bought $49,350 shares of TransCode Therapeutics on Oct 02, 2023 for an estimated value of 25.17K.
Thomas A Fitzgerald TransCode Therapeutics (RNAZ)Interim CEO, CFO, Director
TransCode Therapeutics (RNAZ)
Interim CEO, CFO, Director
Ranked #90,632 out of 98,042 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-92.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Thomas A Fitzgerald's holdings
Insider Roles
Interim CEO, CFO, Director
Roles that Thomas A Fitzgerald holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 17, 2022 - Jun 17, 2023
Return:-89.30%
The most profitable trade made by Thomas A Fitzgerald
Thomas A Fitzgerald's Trading History
List of latest transactions for each holding click on a transaction to see Thomas A Fitzgerald's performance on stock
You May Also Like
Thomas A Fitzgerald insider profile FAQ
What is the percentage of profitable transactions made by Thomas A Fitzgerald?
The percentage of profitable transactions made by Thomas A Fitzgerald is 0%.
What is the average return per transaction made by Thomas A Fitzgerald?
The average return per transaction made by Thomas A Fitzgerald is -92.30%.
What stocks does Thomas A Fitzgerald hold?
Thomas A Fitzgerald holds: RNAZ stocks.
What was Thomas A Fitzgerald’s latest transaction?
Thomas A Fitzgerald latest transaction was an Informative Buy of $25.17K.
What was Thomas A Fitzgerald's most profitable transaction?
Thomas A Fitzgerald’s most profitable transaction was an Informative Buy of RNAZ stock on June 17, 2022. The return on the trade was -89.30%.
What is Thomas A Fitzgerald's role in TransCode Therapeutics?
Thomas A Fitzgerald's role in TransCode Therapeutics is Interim CEO, CFO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.